1. Elkins C, Fruh S, Jones L, Bydalek K. Clinical practice recommendations for pediatric dyslipidemia. J Pediatr Health Care. 2019;33(4):494–504.
2. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(Suppl 5):S213.
3. Ezetimibe product monograph. Merck & CO., Inc. Whitehouse Station, NJ; 2012.
4. Fuenmayor G, Redondo ACC, Shiraishi KS, Souza R, Elias PF, Jatene IB. Prevalence of dyslipidemia in children with congenital heart disease. Arq Bras Cardiol. 2013;101:273–6.
5. Herink M, Ito MK. Medication induced changes in lipid and lipoproteins. In: Endotext. South Dartmouth (MA): MDText.com, Inc; 2018.